As presented here, we identified and described the direct regulation of NR4A2 by miR-34, a well-described tumor suppressor–like miRNA that targets genes involved in cancer progression and is increasingly being exploited for its therapeutic advantage22. The gene discussed is NR4A2; the disease is neoplasm.